🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Status
Recruiting
Location
The fourth hospital of Hebei Medical University
Start Date
2024-11-15
Trial ID
NCT06576921
Treatments Being Tested
This clinical study is in subjects who are 18 years old or older with local...
Status
Completed
Location
Mayo Clinic - Arizona
Start Date
2015-04-21
Trial ID
NCT02301143
Treatments Being Tested
This research study is studying an investigational drug, NC318, as a possib...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12-06
Trial ID
NCT04430933
Treatments Being Tested
In this Phase II study a dose of 2.8 mg (eight 0.35 mg siG12D-LODERs) will ...
Status
Unknown
Location
Hackensack Meridian Health
Start Date
2018-03-07
Trial ID
NCT01676259
Treatments Being Tested
This study aims to evaluate the efficacy and safety of induction Adebrelima...
Status
Not Yet Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2025-08-10
Trial ID
NCT07112833
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
To observe the efficacy and safety of hydrochloride anlotinib combined with...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05772377
Treatments Being Tested
Neoadjuvant Short-Course Radiotherapy Followed by Tislelizumab Plus Chemoth...
Status
Not Yet Recruiting
Location
Tangdu Hospital, Fourth Military Medical University
Start Date
2026-07-10
Trial ID
NCT07678580
This study is a prospective, single-arm, phase II exploratory clinical tria...
Status
Recruiting
Location
The Second Qilu Hospital of Shandong University
Start Date
2024-12-09
Trial ID
NCT07430579
Treatments Being Tested